U.S. Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent … – PharmiWeb.com (press release)
|
U.S. Patent Office to Confirm Kite's Seminal Eshhar CAR-T Patent …
PharmiWeb.com (press release) Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a … |
